Skip to content

Discovery Platform

A Powerful Tech Stack for Validating Difficult Targets

Discover More

Therapeutic Candidates

Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline

Learn More

Latest News and Updates

Press Releases

See iBio's latest press releases
Recent Announcements

Corporate Presentation

Get the most up-to-date company information
View Here

Join us at Drug Discovery Chemistry, April 1-4

Alexander Taguchi, PhD, Director, Machine Learning, Antibody Discovery presents “End-to-End Discovery of Antibodies with Dual Epitope and Tissue Specificity
Learn More

Accelerating Drug Discovery Through AI and Machine Learning

For Investor inquiries, please visit our Investor Site

Visit Here
Top